S. Yamashita

Publications445
h-index54
Citations11,235
Highly Influential Citations406
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • G. Watts
  • 949 Publications, 34,121 Citations
  • Y. Matsuzawa
  • 870 Publications, 84,232 Citations
  • J. Kastelein
  • 650 Publications, 65,025 Citations
  • D. Rader
  • 1,128 Publications, 84,170 Citations
  • Publications
  • Influence
Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.
Fat tissue produces a variety of secreted proteins (adipocytokines) with important roles in metabolism. We isolated a newly identified adipocytokine, visfatin, that is highly enriched in the visceral… Expand
  • 1,263
  • 153
Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty
The presence of obesity increases the risk of thrombotic vascular diseases. The role of fat accumulation and its effect on plasminogen activator inhibitor–1 (PAI–1) levels was investigated in humans… Expand
  • 851
  • 21
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fat tissue produces a variety of secreted proteins (adipocytokines) with important roles in metabolism. We isolated a newly identified adipocytokine, visfatin, that is highly enriched in the visceral… Expand
  • 658
  • 17
Angiopoietin-Like Protein3 Regulates Plasma HDL Cholesterol Through Suppression of Endothelial Lipase
Objectives—A low level of high-density lipoprotein (HDL) in plasma has been recognized as an aspect of metabolic syndrome and as a crucial risk factor of cardiovascular events. However, the… Expand
  • 128
  • 9
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL) cholesterol and causes premature coronary heart… Expand
  • 110
  • 8
  • PDF
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL) cholesterol and causes premature coronary heart… Expand
  • 206
  • 7
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation.
Familial hypercholesterolemia (FH) is a dominantly inherited disorder present from birth that markedly elevates plasma low-density lipoprotein cholesterol and causes premature coronary heart disease.… Expand
  • 109
  • 6
Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.
Plasma cholesteryl ester transfer protein (CETP) facilitates the transfer of cholesteryl ester (CE) from high density lipoprotein (HDL) to apolipoprotein B-containing lipoproteins. Since CETP… Expand
  • 91
  • 6
  • PDF
HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins.
AIM HDL has anti-inflammatory effects on macrophages, although the mechanism of action remains unclear. We hypothesized that HDL suppresses the conversion of macrophage-secreted factors into… Expand
  • 67
  • 6
  • PDF
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia…
Familial hypercholesterolaemia is common in individuals who had a myocardial infarction at a young age. As many as one in 200 people could have heterozygous familial hypercholesterolaemia, and up to… Expand
  • 184
  • 5
  • PDF